• Directory of Taiwan

Hospital Acquired Infections Therapeutic Market 2022: Industry Trends, Growth, Size, Segmentation, Top Players, Share, Upcoming Demand, Regional, Driving Factors, Opportunities and Revenue by Forecast to 2030

The hospital acquired infections therapeutic market size is expected to reach USD 12.02 billion by 2027. Report Ocean presents a new report on hospital acquired infections therapeutic market size, share, growth, industry trends, and forecast 2027, covering various industry elements and growth trends helpful for predicting the market’s future.

Request To Download Sample of This Strategic Report:-

Hospital Acquired Infections Therapeutic Market Report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Rising tolerance towards antibiotics in lethal pathogens also induced the market demand for novel therapeutics for treating hospital acquired infections. The majority of players in the market for hospital acquired infections therapeutic are continuously involved in research & development activities to develop new drugs to gain a competitive advantage.

In this direction, in June 2019, Food & Drug Administration (FDA) approved Merck’s Zerbaxa (ceftolozane and tazobactam) drug for the treatment of ventilator-associated infections in patients aged 18 years and older. This is expected to drive the market for hospital acquired infections therapeutic.

Over the past few decades, chronic diseases such as diabetes, heart-related ailments, and arthritis are rising at an alarming speed. As per the data published by International Agency for Research on Cancer (IARC), in 2018, reported around 18.1 million new cancer cases.

COVID-19 Impact

The COVID-19 pandemic in 2019 engulfed the world. It caused a worldwide halt. The entire global economy was affected. In addition, many people have also lost their lives. Around 252,297,094 cases and 5,091,465 deaths have been reported worldwide so far for COVID-19. The pandemic spread to almost every country in the world. In most industries, the pandemic resulted in some form of loss. As a result of the pandemic, the hospital acquired infections therapeutic market also experienced a slowdown. Statista estimates that the hospital acquired infections therapeutic market total worldwide revenue stood at approximately US$ 3.94 trillion in 2019. In 2014, the hospital acquired infections therapeutic market generated revenues of US$ 5.4 trillion at a record high.

The degree of competition among prominent global companies has been developed by analyzing several leading competitors operating globally. In addition, specialist analysts examine various aspects of the hospital acquired infections therapeutic market, including market competition, market share, the most recent advancements in the industry, innovative product launches, partnerships, mergers, and acquisitions by leading companies.

Request To Download Sample of This Strategic Report:-

This has resulted in a rise in healthcare admissions and an increased possibility of getting an hospital acquired infection. Moreover, as per the data of the New York State Department of Health in November 2019, more than 40% of the adults in the state suffer from some form of chronic disorder, accounting for around 23% of all the hospitalizations.

Asia Pacific is expected to register a lucrative market growth rate over the hospital acquired infection therapeutic study period. This market growth for hospital acquired infection therapeutic is attributed to the rising prevalence of chronic diseases in developing nations with high disposable income, which had led to an increase in hospital admissions.

For instance, as per the market study done by Globocan, in 2018, there were 4,285,033 new cancer cases in China. Thus, with increased hospital admissions, the market demand for hospital acquired infections therapeutics is bound to rise. Market participants such as Merck, Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc., Bayer AG, AbbVie Inc., F. Hoffmann-La Roche Ltd, Daiichi Sankyo Company, Limited and Allergan Plc.

Hospital Acquired Infections Therapeutic, Drug Class Outlook

Antibacterial Drugs

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors


Antiviral Drugs

Antifungal Drugs

Hospital Acquired Infections Therapeutic, Infection Type Outlook

Bloodstream Infections

Surgical Site Infections

Urinary Tract Infections

Ventilator-associated Pneumonia

Other Hospital Infections

Get a Sample PDF copy of the report:-

Hospital Acquired Infections Therapeutic, by Regional Outlook

North America











Asia Pacific





South Korea


Central & South America




Middle East & Africa


Saudi Arabia


South Africa

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)

Updated : 2022-01-28 00:40 GMT+08:00